Authors: FITZSIMMONS WE BEKERSKY I DRESSLER D RAYE K HODOSH E MEKKI Q

Citation: We. Fitzsimmons et al., DEMOGRAPHIC CONSIDERATIONS IN TACROLIMUS PHARMACOKINETICS, Transplantation proceedings, 30(4), 1998, pp. 1359-1364

Authors: BEKERSKY I DRESSLER D BOSWELL GW FERGEN B TRACEWELL W MEKKI Q

Citation: I. Bekersky et al., BIOEQUIVALENCE OF A NEW STRENGTH TACROLIMUS CAPSULE UNDER DEVELOPMENT, Transplantation proceedings, 30(4), 1998, pp. 1457-1459

Authors: BOSWELL G BERKERSKY I MEKKI Q EISENACH J

Citation: G. Boswell et al., PLASMA-CONCENTRATIONS AND DISPOSITION OF CLONIDINE FOLLOWING A CONSTANT 14-DAY EPIDURAL INFUSION IN CANCER-PATIENTS, Clinical therapeutics, 19(5), 1997, pp. 1024-1030

Authors: FLOREN LC BEKERSKY I BENET LZ MEKKI Q DRESSLER D LEE JW ROBERTS JP HEBERT MF

Citation: Lc. Floren et al., TACROLIMUS ORAL BIOAVAILABILITY DOUBLES WITH COADMINISTRATION OF KETOCONAZOLE, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 41-49

Authors: DRESSLER D BEKERSKY I LEE J TRACEWELL WG KISICKI J MEKKI Q

Citation: D. Dressler et al., EFFECT OF MEAL TIME ON TACROLIMUS (T) BIOAVAILABILITY, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 90-90